ASPET President Carol Beck, PhD, speaking at the Opening General Session at the ASPET 2025 Annual Meeting in Portland, Oregon.
  1. Cover Story
  2. May 2025

Experience the ASPET 2025 Annual Meeting

ASPET 2025 Logo

On behalf of the ASPET Council, the ASPET Program Committee, the ASPET 2025 Organizing Committee, and the ASPET staff,

thank you

for making the ASPET 2025 Annual Meeting a resounding success!

ASPET Central

ASPET Central at the ASPET 2025 Annual Meeting in Portland, Oregon.
Attendees had the opportunity to learn more about the Society at ASPET Central, a hub for all things ASPET, including merchandise, information on programs and journals, or to hang out and talk with ASPET staff.
ASPET Central at the ASPET 2025 Annual Meeting in Portland, Oregon.

Awards Luncheon

The Awards Luncheon at the ASPET 2025 Annual Meeting in Portland, Oregon.
ASPET President, Carol Beck [left] and ASPET President-Elect, Randy Hall, serve as co-MCs of the Awards Luncheon at the ASPET 2025 Annual Meeting in Portland, Oregon.
ASPET President, Carol Beck [left] and ASPET President-Elect, Randy Hall, serve as co-MCs of the Awards Luncheon, where members are recognized for various Society, Division-sponsored and poster awards.

Business Meeting

ASPET President, Carol Beck and ASPET President-Elect, Randy co-host the Business Meeting at the ASPET 2025 Annual Meeting in Portland, Oregon.
ASPET President, Carol Beck and ASPET President-Elect, Randy Hall co-host the Business Meeting.

ASPET Executive Officer, Dave Jackson and Secretary/Treasurer, Pamela Hornby, also presented at the Business Meeting.

Career Connections

Attendees met in group settings to learn more about career opportunities for pharmacologists at the ASPET 2025 Annual Meeting in Portland, Oregon.
Attendees met in one-on-one and group settings to learn more about career opportunities for pharmacologists at ASPET 2025.
Attendees met one-on-one to learn more about career opportunities for pharmacologists at the ASPET 2025 Annual Meeting in Portland, Oregon.

Concurrent Sessions

At the ASPET 2025 Annual Meeting in Portland, Oregon, attendees had front-row seats to the latest advances in pharmacology and experimental therapeutics, presented by the brightest minds in the field.
ASPET 2025 attendees had front-row seats to the latest advances in pharmacology and experimental therapeutics, presented by the brightest minds in the field.
At the ASPET 2025 Annual Meeting in Portland, Oregon, attendees had front-row seats to the latest advances in pharmacology and experimental therapeutics, presented by the brightest minds in the field.

Divisions

At the ASPET 2025 Annual Meeting in Portland, Oregon, Divisions held specially-focused sessions on topic areas of interest to their members, including Cancer pharmacology, clinical pharmacology, and drug development.

Divisions held specialty-focused sessions on topic areas of interest to their members, including Cancer pharmacology, clinical pharmacology, and drug development.

At the ASPET 2025 Annual Meeting in Portland, Oregon, Divisions held specially-focused sessions on topic areas of interest to their members, including Cancer pharmacology, clinical pharmacology, and drug development.
At the ASPET 2025 Annual Meeting in Portland, Oregon, Divisions held specially-focused sessions on topic areas of interest to their members, including Cancer pharmacology, clinical pharmacology, and drug development.

Keynote Speakers

Tamer Coskun, MD, PhD

Dr. Tamer Coskun of Eli Lilly discussed the pharmacological development of tirzepatide and retatrutide from early discovery to clinical outcomes, during his keynote session, “Development of Multi-functional Incretins for Diabetes and Obesity,” at the ASPET 2025 Annual Meeting in Portland, Oregon.
Dr. Tamer Coskun of Eli Lilly discussed the pharmacological development of tirzepatide and retatrutide from early discovery to clinical outcomes, during his keynote session, “Development of Multi-functional Incretins for Diabetes and Obesity,” at the Annual Meeting.
Dr. Tamer Coskun of Eli Lilly discussed the pharmacological development of tirzepatide and retatrutide from early discovery to clinical outcomes, during his keynote session, “Development of Multi-functional Incretins for Diabetes and Obesity,” at the ASPET 2025 Annual Meeting in Portland, Oregon.

Laura Kleiman, PhD

Dr. Laura Kleiman, Founder and CEO of Reboot Rx, talked about the tremendous opportunities in drug repurposing for cancer in her keynote session titled “Unlocking Access to Cancer Care with Repurposed Generic Drugs and AI” at the ASPET 2025 Annual Meeting in Portland, Oregon.

Dr. Laura Kleiman, Founder and CEO of Reboot Rx, talked about the tremendous opportunities in drug repurposing for cancer in her keynote session titled “Unlocking Access to Cancer Care with Repurposed Generic Drugs and AI” at ASPET 2025.

Dr. Laura Kleiman, Founder and CEO of Reboot Rx, talked about the tremendous opportunities in drug repurposing for cancer in her keynote session titled “Unlocking Access to Cancer Care with Repurposed Generic Drugs and AI” at the ASPET 2025 Annual Meeting in Portland, Oregon.
Dr. Laura Kleiman, Founder and CEO of Reboot Rx, talked about the tremendous opportunities in drug repurposing for cancer in her keynote session titled “Unlocking Access to Cancer Care with Repurposed Generic Drugs and AI” at the ASPET 2025 Annual Meeting in Portland, Oregon.

Camille Crittenden, PhD

Dr. Camille Crittenden, Executive Director of CITRIS and the Banatao Institute, presented on the transformative potential of AI across the drug development pipeline in her keynote session, “Digital Transformation in Pharmacology: Applications of Responsible AI for the Next Generation of Therapeutic Research,” at the ASPET 2025 Annual Meeting in Portland, Oregon.
Dr. Camille Crittenden, Executive Director of CITRIS and the Banatao Institute, presented on the transformative potential of AI across the drug development pipeline in her keynote session, “Digital Transformation in Pharmacology: Applications of Responsible AI for the Next Generation of Therapeutic Research,” at the Annual Meeting.
Dr. Camille Crittenden, Executive Director of CITRIS and the Banatao Institute, presented on the transformative potential of AI across the drug development pipeline in her keynote session, “Digital Transformation in Pharmacology: Applications of Responsible AI for the Next Generation of Therapeutic Research,” at the ASPET 2025 Annual Meeting in Portland, Oregon.

Anthony Leung, PhD

Dr. Anthony Leung, a professor at Johns Hopkins University, discussed his ADP-ribosylation research findings in his keynote session titled “Beyond Cancer: PARP Biology in Biomolecular Condensates and Emerging Roles in Infection and Neurodegeneration” at the ASPET 2025 Annual Meeting in Portland, Oregon.
Dr. Anthony Leung, a professor at Johns Hopkins University, discussed his ADP-ribosylation research findings in his keynote session titled “Beyond Cancer: PARP Biology in Biomolecular Condensates and Emerging Roles in Infection and Neurodegeneration” at the ASPET 2025 Annual Meeting in Portland, Oregon.
Dr. Anthony Leung, a professor at Johns Hopkins University, discussed his ADP-ribosylation research findings in his keynote session titled “Beyond Cancer: PARP Biology in Biomolecular Condensates and Emerging Roles in Infection and Neurodegeneration.”

Community Service

Twenty-five attendees of the ASPET 2025 Annual Meeting in Portland, Oregon volunteered to help at the annual community service project. This year, they visited Transition Projects, a non-profit organization that helps transition people from homelessness into housing in the Portland metropolitan area.
Twenty-five attendees of the ASPET 2025 Annual Meeting in Portland, Oregon volunteered to help at the annual community service project. This year, they visited Transition Projects, a non-profit organization that helps transition people from homelessness into housing in the Portland metropolitan area.
Twenty-five attendees of the ASPET 2025 Annual Meeting in Portland, Oregon volunteered to help at the annual community service project. This year, they visited Transition Projects, a non-profit organization that helps transition people from homelessness into housing in the Portland metropolitan area.

Twenty-five ASPET attendees volunteered to help at the annual community service project during ASPET 2025. This year, they visited Transition Projects, a non-profit organization that helps transition people from homelessness into housing in the Portland metropolitan area.

Opening Session

The ASPET 2025 Annual Meeting Opening Session speaker, Dr. Tamer Coskun of Eli Lilly, discussed pharmacological development of tirzepatide and retatrutide from early discovery to clinical outcomes.

The Opening Session speaker, Dr. Tamer Coskun of Eli Lilly discussed pharmacological development of tirzepatide and retatrutide from early discovery to clinical outcomes. The opening was hosted by ASPET President Carol Beck and attendees were welcomed to Portland by Desiree Everett, Vice President of Convention Sales & Services at Travel Portland.

ASPET President Carol Beck hosted the Opening Session at the ASPET 2025 Annual Meeting in Portland, Oregon.
ASPET President Carol Beck hosted the ASPET 2025 Opening Session.
Desiree Everett, Vice President of Convention Sales & Services at Travel Portland, welcomed ASPET 2025 Annual Meeting attendees to Portland, Oregon.
Desiree Everett, Vice President of Convention Sales & Services at Travel Portland, welcomed ASPET 2025 attendees.
ASPET Executive Officer Dave Jackson also presented during the Opening Session at the ASPET 2025 Annual Meeting in Portland, Oregon.
ASPET Executive Officer Dave Jackson also presented during the ASPET 2025 Opening Session.

Poster Sessions

At the ASPET 2025 Annual Meeting in Portland, Oregon, daily poster competitions were held for early-career scientists to present their latest research, where they met and talked with judges and other attendees interested in their work.

Daily poster competitions were held for early-career scientists to present their latest research, where they met and talked with judges and other attendees interested in their work.

At the ASPET 2025 Annual Meeting in Portland, Oregon, daily poster competitions were held for early-career scientists to present their latest research, where they met and talked with judges and other attendees interested in their work.
At the ASPET 2025 Annual Meeting in Portland, Oregon, daily poster competitions were held for early-career scientists to present their latest research, where they met and talked with judges and other attendees interested in their work.

The Loft at 5th Avenue

Portland may boast about its weirdness, but ASPET 2025 Annual Meeting opening night attendees got an opportunity to mingle, network and enjoy an atmosphere of food and fun with some of Portland’s gnomes! #StayWeirdPortland

Portland may boast about its weirdness, but on opening night attendees got an opportunity to mingle, network and enjoy an atmosphere of food and fun with some of Portland’s gnomes! #StayWeirdPortland

Portland may boast about its weirdness, but ASPET 2025 Annual Meeting opening night attendees got an opportunity to mingle, network and enjoy an atmosphere of food and fun with some of Portland’s gnomes! #StayWeirdPortland

Journal One-on-One

Habibeh Koshbouei [left], an Associate Editor for Pharmacological Reviews, met with an attendee to discuss her research idea during Elsevier’s Meet the Editor opportunities at ASPET 2025.

Habibeh Koshbouei [left], an Associate Editor for Pharmacological Reviews, met with an attendee to discuss her research idea during Elsevier’s Meet the Editor opportunities at ASPET 2025.